WAVE LIFE SCIENCES LTD. Increase (Decrease) in Restricted Cash
WAVE LIFE SCIENCES LTD. (WVE) reported Increase (Decrease) in Restricted Cash of $9.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-03-12
- WAVE LIFE SCIENCES LTD. increase (decrease) in restricted cash for the quarter ending 2017-12-31 was $2.00K.
- WAVE LIFE SCIENCES LTD. increase (decrease) in restricted cash for the quarter ending 2017-09-30 was $2.00K.
- WAVE LIFE SCIENCES LTD. increase (decrease) in restricted cash for the quarter ending 2017-06-30 was $2.00K.
- WAVE LIFE SCIENCES LTD. increase (decrease) in restricted cash for the quarter ending 2017-03-31 was $3.00K.
- WAVE LIFE SCIENCES LTD. increase (decrease) in restricted cash for fiscal 2017 was $9.00K, a 99.65% decline from fiscal 2016.
- WAVE LIFE SCIENCES LTD. increase (decrease) in restricted cash for fiscal 2016 was $2.60M, a 146.35% increase from fiscal 2015.
- WAVE LIFE SCIENCES LTD. increase (decrease) in restricted cash for fiscal 2015 was $1.05M.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2017-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $4.00K derived: sum of 2 quarters · filed 2018-03-12 | $6.00K derived: sum of 3 quarters · filed 2018-03-12 | $9.00K 10-K · filed 2018-03-12 |
| 2017-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $4.00K derived: sum of 2 quarters · filed 2017-11-09 | $7.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $5.00K 10-Q · filed 2017-08-09 | ||
| 2017-03-31 | $3.00K 10-Q · filed 2017-05-10 | |||
| 2016-12-31 | $2.60M 10-K · filed 2018-03-12 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $0.00 derived: sum of 2 quarters · filed 2018-03-12 | $1.00M derived: sum of 3 quarters · filed 2018-03-12 | $1.05M 10-K · filed 2018-03-12 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.00M derived: sum of 2 quarters · filed 2016-11-09 | $1.05M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $1.05M 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | $55.00K 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |